Transcranial Magnetic Stimulation trials

Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease

RecruitingNCT05808504Phase: NAStarted 2023-05-03

Summary

Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's disease. It is mostly characterized by the presence of motor difficulties. However, it can also be accompanie

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
75 Years

Locations

CHU de RennesRennes, France

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT05808504